$MRK Headlines Novartis divestiture move expected, but

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$MRK Headlines

Novartis divestiture move expected, but with another partner, analyst says 12:52 p.m. April 22, 2014 - blogs.marketwatch.com
GlaxoSmithKline exits cancer drugs 8:36 a.m. April 22, 2014 - MarketWatch.com
5 mid-cap stocks that insiders love 12:10 p.m. April 17, 2014 - Insider Monkey
Merck: Hepatitis C drug has 98% cure rate in trial 11:43 a.m. April 10, 2014 - MarketWatch.com
Merck rises 1.5% to lead Dow gainers 9:33 a.m. April 10, 2014 - William L. Watts
Cisco, Merck, Visa lead Dow gainers 9:32 a.m. April 9, 2014 - William L. Watts
How sector stock funds can make your portfolio whole 7:01 a.m. April 7, 2014 - Jonathan Burton
The market’s rigged, you say? When wasn’t it? 12:03 p.m. April 3, 2014 - David Weidner
3 red-hot investment opportunities 8:40 a.m. April 3, 2014 - Jeff Reeves
Best, worst stocks of the $100 billion club: Morgan Stanley 2:03 p.m. March 31, 2014 - blogs.marketwatch.com
Play-it-safe stock investors may take some risk on jobs 8:30 a.m. March 30, 2014 - Wallace Witkowski
Microsoft, Merck lead early Dow gainers 9:32 a.m. March 28, 2014 - William L. Watts
When it rains, it pours for Nasdaq leadership 12:47 p.m. March 27, 2014 - The Trading Deck
Investors may need to go long if they hope to reap Baxter spinoff rewards 11:40 a.m. March 27, 2014 - blogs.marketwatch.com
Merck, Glaxo delay helping Affordable Care co-pays 4:33 p.m. March 26, 2014 - MarketWatch.com
Germany's Merck to propose 2-for-1 stock split 12:26 p.m. March 26, 2014 - MarketWatch.com
Merck, Cisco lead Dow gainers 9:33 a.m. March 26, 2014 - William L. Watts
3M, Merck lead Dow gainers 9:34 a.m. March 25, 2014 - William L. Watts
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
A tax-friendly alternative to municipal bonds 5:00 a.m. Feb. 27, 2014 - Amit Chopra


5 Dow Stocks Seeing an Outstanding 2014 8:04 a.m. Today - Wall St. Cheat Sheet
Biotech: The Poster Child for Market Volatility in 2014 7:32 a.m. Today - 247WallSt.com
Disappointments? Think Opportunities; Miracle Drug May Be Ailing Gilead: Jim Cramer's Best Blogs 6:00 a.m. Today - TheStreet.com
Is The Vanguard High Dividend Yield ETF Primed For Dividend Growth? 6:04 p.m. April 25, 2014 - Seeking Alpha
Week Ahead: April Jobs Report, FOMC Meeting and Earnings 4:39 p.m. April 25, 2014 - FOXBusiness
Q1 Earnings: A Stronger Weakling than Originally Thought - Earnings Preview 5:32 a.m. April 25, 2014 - Zacks.com
Costly Hepatitis Drugs Vex Prisons 5:23 p.m. April 24, 2014 - The Wall Street Journal Interactive Edition
Merck, P&G and Other Dividend Stocks You Wish You'd Bought in 2013 6:00 a.m. April 24, 2014 - TheStreet.com
Gilead, Illumina Q1 Earnings Win Wall Street's Love 10:39 a.m. April 23, 2014 - Investors Business Daily
Stock Market News for April 23, 2014 - Market News 10:06 a.m. April 23, 2014 - Zacks.com
UBS Top Stocks to Buy Working for Cancer Cures 7:52 a.m. April 23, 2014 - 247WallSt.com
Global Drug Industry Does About-Face 10:12 p.m. April 22, 2014 - The Wall Street Journal Interactive Edition
Drugmakers Prod European Stocks To Post-Easter Rally 5:36 p.m. April 22, 2014 - Investors Business Daily
Novartis, Glaxo Swap Units; Valeant Bids For Allergan 4:50 p.m. April 22, 2014 - Investors Business Daily
Novartis, Glaxo Swap Units; Lilly Buying Animal Biz 10:49 a.m. April 22, 2014 - Investors Business Daily
Stock Market News for April 22, 2014 - Market News 10:06 a.m. April 22, 2014 - Zacks.com
Glaxo Exits Cancer Drugs 8:19 a.m. April 22, 2014 - The Wall Street Journal Interactive Edition
Big Brands to Be United in Joint Venture 5:08 a.m. April 22, 2014 - The Wall Street Journal Interactive Edition
Is Pfizer a Good Portfolio Play? 5:40 p.m. April 21, 2014 - Wall St. Cheat Sheet
Merck & Co Inc (MRK): Today's Featured Health Care Winner 5:00 p.m. April 21, 2014 - TheStreet.com


Schedule for Upcoming Earnings Releases -- Research on Nokia, Boston Scientific, Merck & Co., and Bristol-Myers Squibb 2:09 p.m. April 25, 2014 - PR Newswire - PRF
Andrzej S. Krolewski, MD, PhD, Receives American Diabetes Association's Kelly West Award for Outstanding Achievement in Epidemiology 12:00 p.m. April 25, 2014 - Marketwire
EMD Serono Presents New Data on Rebif® (interferon beta-1a) and Advancing MS Pipeline at AAN Annual Meeting 9:00 a.m. April 25, 2014 - PR Newswire - PRF
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Chugai Pharma USA Announces Appointment of Chief Medical Officer 2:00 a.m. April 25, 2014 - PR Newswire - PRF
Fitch Affirms Merck & Co.'s Long-term IDR at 'A+'; Outlook Remains Negative 2:24 p.m. April 24, 2014 - BusinessWire - BZX
Global NGO Project HOPE Launches Education Initiative on HPV Infection Prevention in China 9:28 a.m. April 24, 2014 - GlobeNewswire
Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Andrzej S. Krolewski, MD, PhD, Receives American Diabetes Association's Kelly West Award for Outstanding Achievement in Epidemiology 1:13 p.m. April 23, 2014 - Marketwire
Edward S. Horton, MD, Receives American Diabetes Association's Albert Renold Award 1:12 p.m. April 23, 2014 - Marketwire
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth 1:05 p.m. April 23, 2014 - PR Newswire - PRF
Merck and Award-Winning Actress S. Epatha Merkerson Challenge Americans with Type 2 Diabetes to Get to Their Goals 8:00 a.m. April 23, 2014 - PR Newswire - PRF
Oral Hygiene Market in the United Kingdom to 2017: Market Size, Distribution and Brand Share, Key Events and Competitive Landscape 12:45 p.m. April 22, 2014 - PR Newswire - PRF
Merck among NASA Cargo Launching to Space Station 4:15 p.m. April 21, 2014 - PR Newswire - PRF
FDA Approves Merck’s RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Adults 6:22 p.m. April 17, 2014 - BusinessWire - BZX
Merck Serono's President & CEO Belén Garijo has Been Appointed to Board of Directors of L'Oréal 12:37 p.m. April 17, 2014 - PR Newswire - PRF
Brain Cancer Global Clinical Trials Review, H1, 2014 12:25 p.m. April 17, 2014 - PR Newswire - PRF
Physicians Interactive's Transformative Omnio Medical App Expands from iPad to iPhone, Android Versions 7:54 a.m. April 16, 2014 - PR Newswire - PRF
Global Veterinary Vaccines Industry 12:06 p.m. April 15, 2014 - PR Newswire - PRF
Interim Clinical Study Results, Leadership Appointments, and Earnings Release Schedules - Analyst Notes on Merck, Magellan, ABIOMED, CONMED, and Greatbatch 8:00 a.m. April 15, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tech Job Market Surges: 86,000 Hires in August Boost

Updated Category News Views 2

Tech Job Growth Defies Corporate Layoffs Job markets in the tech world are hotter than a two-dollar pistol. Despite seeing some layoffs in tech firms, the demand for skilled tech workers is still booming. You got tech companies tightening the bolts, laying off around 14,700 folks, but here's the kicker: overall tech employment shot up with 86,000 new jobs in August....

Continue Reading
CHiQ Secures AI Award, Elevates Smart Home Living

Updated Category News Views 1

CHiQ's Big Win in the AI Game In a world where technology rarely stops spinning, CHiQ has carved its own commendable niche. Snagging the AI Home Ecosystem Brand Award at IFA 2026 in Berlin, the brand's knack for pioneering AI tech isn't just a footnote—it's the whole story. The award—enough to make your competitors green with envy—highlights how far they've come in...

Continue Reading
IVD Study Success: Hybrid Monitoring Boosts Oversight

Updated Category News Views 1

New Strategies for IVD Clinical Studies It's high time we addressed the tangled web of managing in vitro diagnostic (IVD) clinical studies. We're talking about walking a tightrope where sponsors have to juggle regulatory scrutiny, data integrity, and operational efficiency—all while pushing innovation. Simply put, the old ways of doing things just aren't cutting it...

Continue Reading
Reolink Unveils OMVI 2i Ultra at IFA 2026

Updated Category News Views 6

Reolink's Bold Move Into the Future of Home Security Amidst the hustle of Berlin's IFA 2026, Reolink dropped its latest gem: the OMVI 2i Ultra—an all-in-one security powerhouse promising to change the game for home protection junkies. As usual, Reolink's got its eyes on the prize, pushing boundaries with this latest lineup. OMVI 2i Ultra: Dual-View Revolution If you've...

Continue Reading
Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 5

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
AEVEX Faces $100K+ Losses in New Investor Lawsuit

Updated Category News Views 1

When the suits start flying, folks, you know there's a mess brewing somewhere in the market. Here we are, talking about AEVEX Corp, ticker NYSE:AVEX, and they’re facing some serious heat. There's some scuttlebutt about a class action lawsuit that’s got investors clutching onto their wallets tighter than ever. If you’ve been scouring over the papers, this lawsuit is...

Continue Reading
Rho Adds Credit Card Payments to Invoices

Updated Category News Views 2

Rho's New Game: Credit Card Payments on Invoices Ah, the wonderful world where your invoices can finally ride the plastic wave! Rho, that scrappy finance platform everyone's been chattering about, just rolled out a card payment feature. Yep, from credit cards to Google Pay, they’re letting businesses skip the usual financial hurdles and get their dough directly from...

Continue Reading
CRESYN Opens Model Residence: A Peek at City Living

Updated Category News Views 3

CRESYN: Urban Elegance Hits Long Island City Who doesn't want to peek under the hood when a flashy new ride rolls into town? CRESYN's newly unveiled model residence in Long Island City is just that—an invitation to get up close and personal with what modern urban living can be. Forget the blueprints and glossy renderings. This place is the real deal, giving you that...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 2

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyst Insights on Humana's Q3 Earnings Expectations

Updated Category News Views 198

Analyst Insights on Humana's Q3 Earnings Expectations As Humana prepares for its upcoming earnings report, analysts are closely examining the expected performance metrics. The consensus among Wall Street experts is that Humana (NYSE: HUM) will report earnings of approximately $3.48 per share. This figure marks a notable decline of 55.3% compared to the same quarter last...

Continue Reading
Mastering Price Breakouts: Avoid Common Trading Pitfalls

Updated Category News Views 277

Understanding Price Breakouts in Trading Price breakouts are captivating setups in the trading world. However, traders often find themselves misled when relying solely on price movements without considering essential indicators. The reality of the market is that many breakouts are merely illusions that can deceive traders unprepared for unexpected reversals. Recognizing...

Continue Reading
Maximize Earnings: Earning $500 Monthly with Pfizer Stock

Updated Category News Views 108

Unlocking Earnings Potential with Pfizer Pfizer Inc. (NYSE: PFE) has positioned itself uniquely in the healthcare sector, and as it approaches its third-quarter earnings announcement, many investors are contemplating the opportunities its stock presents. Analysts anticipate that Pfizer will report earnings around 64 cents per share, a decrease compared to $1.06 in the...

Continue Reading
Addressing Unfair Trade Practices in the Trailer Industry

Updated Category News Views 215

The Urgent Need for Trade Protection in the Trailer Industry Undoubtedly, the American trailer industry is at a critical juncture. Recent actions by the American Trailer Manufacturers Coalition highlight the pressing need for antidumping and countervailing duties as imports of van trailers from foreign countries like China, Canada, and Mexico flood the market at unfairly...

Continue Reading
Genius Group Marks Another Milestone with Recent Buyback

Updated Category News Views 145

Genius Group Executes Share Buyback to Boost Investor Value Genius Group Limited (NYSE: GNS), a pioneering entity in the AI-driven education sector, has made headlines with its recent buyback of one million shares, a strategic move undertaken to reinforce shareholder confidence and value. This transaction occurred against the backdrop of a well-defined plan, allowing the...

Continue Reading